Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04322669

Study of Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI) — P-CRESCENT  

Recurrent Respiratory Tract Infections Clinical Trial

Official title:
Pidotimod in Children With Recurrent Respiratory Tract Infections (RRI), A Randomized, Double Blind, Placebo Controlled Clinical Trial (P-CRESCENT)

Clinical Trial Summary

The purpose of this study is to assess the efficacy of pidotimod as treatment in participants with recurrent respiratory tract infections.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04322669
Study type Interventional
Source Almirall, S.A.
Contact
Status Completed
Phase Phase 4
Start date August 4, 2021
Completion date November 4, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT02617771 - Impact of Vitamin D Supplementation on Recurrent Respiratory Infections in Paediatric Primary Care. Phase 4
Not yet recruiting NCT05053776 - Clinical and Laboratory Predictors of Respiratory Morbidities in CP Children
Terminated NCT04408443 - Evaluation of Lactobacillus Reuteri DSM 17938 + Vitamin D3 in the Prevention of RRI in Paediatric Patients N/A
Recruiting NCT05684848 - Evaluate the Effect of Nasal Spray in the Prevention of RTI in Children With Pre-school Wheezing N/A
Recruiting NCT06201494 - Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents